Health and medical news from independent sources.
The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood pressure feature.
Can the quality of generic drugs in the U.S. be made more consistent? One expert has some ideas on how to do it.
The federal government can't block benefits from the nation's largest food aid program from being used to buy candy, soda, and other sugary drinks, a judge ruled.
The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests.
Giving an individual special access to an experimental obesity drug is highly unusual.
The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
In this edition of STAT Health Tech: OpenEvidence adds AI to detect heart disease, and Cadence raises $100 million, and more.
FDA's early-stage clinical trial program, a mysterious single patient gets retatrutide access, and more health news from Morning Rounds
Digital health startup Cadence has raised $100 million at a $1.23 billion valuation to expand its chronic disease management program.
A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a reverse-merger with a preexisting biotech company.
Medicare is testing the use of artificial intelligence to preapprove several healthcare services. Federal health officials say prior authorization can help reduce fraud and contain costs. But doctors and patients describe the trial as “horrendous” and full of red tape so far.
Being a caregiver can start long before you go to a doctor appointment with a loved one or move your parents into your house. The HealthQ team explores how embracing the role matters — and how the recognition and support that come next can ease a difficult season of life.
“There's a particular cruelty buried in the new Medicaid work requirement rules,” write Maria Town and Nicole Jorwic.
EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart diseases.
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
If the Supreme Court upholds the executive order ending birthright citizenship, it could “have stark consequences at the intersection of bioethics and public health.”
A new memo from the Department of Justice seeks to upend landmark disability laws and court rulings.
Pfizer said an experimental drug it hoped could replace a widely used chemotherapy in one of the most common forms of lung cancer fell short in a clinical trial.
Federal health officials aim to speed up drug development and better compete with China.